These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 15026025)

  • 1. A freeze-dried fibrin disc as a biodegradable drug release matrix.
    Kumar TR; Vasantha Bai M; Krishnan LK
    Biologicals; 2004 Mar; 32(1):49-55. PubMed ID: 15026025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro evaluation of PCL-TCP composites as delivery systems for platelet-rich plasma.
    Rai B; Teoh SH; Ho KH
    J Control Release; 2005 Oct; 107(2):330-42. PubMed ID: 16085332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin-antibiotic mixtures: an in vitro study assessing the possibility of using a biologic carrier for local drug delivery.
    Greco F; de Palma L; Spagnolo N; Rossi A; Specchia N; Gigante A
    J Biomed Mater Res; 1991 Jan; 25(1):39-51. PubMed ID: 2019611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
    Jeon O; Kang SW; Lim HW; Hyung Chung J; Kim BS
    Biomaterials; 2006 Mar; 27(8):1598-607. PubMed ID: 16146647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma.
    Ranganath SH; Wang CH
    Biomaterials; 2008 Jul; 29(20):2996-3003. PubMed ID: 18423584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication and physical and biological properties of fibrin gel derived from human plasma.
    Zhao H; Ma L; Zhou J; Mao Z; Gao C; Shen J
    Biomed Mater; 2008 Mar; 3(1):015001. PubMed ID: 18458488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular weight fibrinogen variants determine angiogenesis rate in a fibrin matrix in vitro and in vivo.
    Kaijzel EL; Koolwijk P; van Erck MG; van Hinsbergh VW; de Maat MP
    J Thromb Haemost; 2006 Sep; 4(9):1975-81. PubMed ID: 16961604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fibrin encapsulated liposomes-in-chitosan matrix (FLCM) for delivering water-soluble drugs. Influences of the surface properties of liposomes and the crosslinked fibrin network.
    Chung TW; Yang MC; Tsai WJ
    Int J Pharm; 2006 Mar; 311(1-2):122-9. PubMed ID: 16446064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding.
    Vaz CM; van Doeveren PF; Dias GR; Reis RL; Cunha AM
    Macromol Biosci; 2004 Aug; 4(8):795-801. PubMed ID: 15468273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin-filled scaffolds for bone-tissue engineering: An in vivo study.
    Karp JM; Sarraf F; Shoichet MS; Davies JE
    J Biomed Mater Res A; 2004 Oct; 71(1):162-71. PubMed ID: 15368266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new biocompatible nanoparticle delivery system for the release of fibrinolytic drugs.
    Piras AM; Chiellini F; Fiumi C; Bartoli C; Chiellini E; Fiorentino B; Farina C
    Int J Pharm; 2008 Jun; 357(1-2):260-71. PubMed ID: 18313868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of fibrin sealants for the localized, controlled release of cefazolin.
    Tredwell S; Jackson JK; Hamilton D; Lee V; Burt HM
    Can J Surg; 2006 Oct; 49(5):347-52. PubMed ID: 17152573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
    Cai S; Liu Y; Zheng Shu X; Prestwich GD
    Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gentamicin release from two-solution and powder-liquid poly(methyl methacrylate)-based bone cements by using novel pH method.
    Merkhan IK; Hasenwinkel JM; Gilbert JL
    J Biomed Mater Res A; 2004 Jun; 69(3):577-83. PubMed ID: 15127405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of drugs from multi-component biomaterials.
    Zalfen AM; Nizet D; Jérôme C; Jérôme R; Frankenne F; Foidart JM; Maquet V; Lecomte F; Hubert P; Evrard B
    Acta Biomater; 2008 Nov; 4(6):1788-96. PubMed ID: 18583206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of hybrid scaffold from fibrin and biodegradable polymer fiber.
    Hokugo A; Takamoto T; Tabata Y
    Biomaterials; 2006 Jan; 27(1):61-7. PubMed ID: 16000222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive in vivo tracking of fibrin degradation by fluorescence imaging.
    Wolbank S; Pichler V; Ferguson JC; Meinl A; van Griensven M; Goppelt A; Redl H
    J Tissue Eng Regen Med; 2015 Aug; 9(8):973-6. PubMed ID: 25044309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
    Tallury P; Alimohammadi N; Kalachandra S
    Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems.
    Wood MD; Sakiyama-Elbert SE
    J Biomed Mater Res A; 2008 Feb; 84(2):300-12. PubMed ID: 17607752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H; Bodmeier R
    Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.